Todd C Brady insider trades

Open-market stock purchases and sales by Todd C Brady, President and CEO at Aldeyra Therapeutics, Inc, from SEC Form 4 filings since Sep 24, 2013.

Track record: 7% of 15 scored buys are up 5% or more since purchase, averaging -74%.

Recent trades

DateStockTradeValue
Jun 3, 2026ALDX Aldeyra Therapeutics, IncBought$418K
Mar 27, 2026ALDX Aldeyra Therapeutics, IncBought (not open market)—
Mar 27, 2026ALDX Aldeyra Therapeutics, IncBought (not open market)—
Dec 17, 2025EVOK Evoke Pharma IncSold (not open market)$6.6K
Dec 17, 2025EVOK Evoke Pharma IncSold (not open market)$26K
Dec 17, 2025EVOK Evoke Pharma IncSold (not open market)$4.1K
Dec 16, 2025EVOK Evoke Pharma IncSold (not open market)—

Companies traded

  • ALDX Aldeyra Therapeutics, Inc: 14 buys, 2 sales, last Jun 3, 2026
  • EVOK Evoke Pharma Inc: 1 buy, last Dec 17, 2025
  • FSTX F-star Therapeutics, Inc: other filings, last Mar 8, 2023
  • SBPH F-star Therapeutics, Inc: other filings, last Nov 19, 2020
  • ONS Oncobiologics, Inc: other filings, last Oct 26, 2017

Get free alerts when Todd C Brady files a new trade →